Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi): What’s up Applied Genetic Technologies (AGTC)?

September 28, 2022 7:57am

Trying to HIDE end-of-year Annual Report (10-K) status and an S-8 registration Statement for proposed offering?

Still has a “going concern” status, considered good for the time being? It means its business is facing financial distress but is still able to make payments to keep it operating at least the next 12 months.

Recurring losses, accumulated deficit of $308.2 million and a fading share pricing at $0.30 with a 52-week change of -90.87% (low of $0.28 and a high of $3.295)

Is AGTC has filed for an offering proposing sale of 2,035,281 shares to raise $631,867.11?

The 10-K noted a 2023 loss of -$68.94 m or -$1.53 with $46.4 million in cash and a runway until Q3/23

While Sue washer CEO has a base salary of $575, 000. And just received a $185,055.00 bonus on 8/23

10-K (HTML) … https://ir.agtc.com/node/11891/html

S-8 (HTML)… https://ir.agtc.com/node/11896/html

The Bottom Line: Investors should read SEC filings, a lot of words but discerning readers know where to look and translate … the lack of AGTC’s managements investor appreciation!

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

3 hours 54 min ago
RegMed Investors’ (RMi) pre-open: expectation versus reality

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.